Your session is about to expire
← Back to Search
Behavioral Intervention
ADELANTE for HIV
N/A
Recruiting
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Lacks capacity to consent (measured by a validated screener)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month-12
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to see if ADELANTE, a community health worker-delivered intervention, is more effective than enhanced care in helping Latinos with HIV achieve viral suppression. Participants will either receive ADE
Who is the study for?
This trial is for Latinos with HIV who are struggling to keep the virus under control. Participants will be randomly assigned to receive either a new intervention called ADELANTE, which includes five sessions with a community health worker, or an enhanced care condition involving five reminder phone calls.
What is being tested?
The study aims to see if ADELANTE can help participants better manage their HIV and achieve viral suppression compared to those receiving just reminder calls. The success of the program will be measured by checking rates of viral suppression and tracking emergency room visits and hospitalizations over a year.
What are the potential side effects?
Since ADELANTE is a behavioral intervention involving problem-solving sessions with a health worker, it does not have medical side effects like drugs do. However, participants may experience emotional discomfort discussing personal issues related to their HIV care.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand and make decisions about my treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month-12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month-12
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
12-month viral suppression
Secondary study objectives
6-month viral suppression
Number of Emergency department visits
Number of Hospitalizations
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ADELANTEExperimental Treatment1 Intervention
Participants will receive 5, individualized problem solving sessions delivered by a community health worker over 6 months. The intervention content is framed around a bi-lingual film about HIV.
Group II: Enhanced Care ConditionActive Control1 Intervention
Participants in the enhanced care control group will receive 5 locator phone calls confirming contact information at the same interval as CHW sessions in the ADELANTE group. They will be offered routine HIV health promotion materials as is available in the clinic. If a participant requests support for navigation or case management, they will be encouraged to contact their HIV team
Find a Location
Who is running the clinical trial?
Baylor College of MedicineOTHER
1,028 Previous Clinical Trials
6,029,912 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,570 Total Patients Enrolled
University of MiamiOTHER
955 Previous Clinical Trials
428,603 Total Patients Enrolled